ArticleBMC cancer2016

Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.

Mamoru Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.